Ginsburg Appointed to ACPE Board of Directors

Headshot of Dr. Diane Ginsburg.
December 11, 2023
Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg was appointed to the Accreditation Council for Pharmacy Education (ACPE) Board of Directors effective July 1, 2024. ACPE is the national agency for the accreditation of professional degree programs in pharmacy and providers of continuing pharmacy education.

Popular OTC Medicines for Colds and Allergies Don’t Work, FDA Panel Says

Rows of boxes of ineffective nasal decongestants.
September 12, 2023
An independent advisory committee to the FDA has determined that phenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines, is ineffective in tablet form. CNN and numerous other national news outlets quote from the College of Pharmacy's Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg, who serves on the committee, regarding this decision.

Texas Pharmacy Exceeds Residency Match Placement Goals

91% Residency Match Placement. National Average: 82%. The University of Texas at Austin College of Pharmacy. American Society of Health-System Pharmacists, 2023 Pharmacy Residency Match.
May 4, 2023
The University of Texas at Austin College of Pharmacy placed in the top ten in the entire country in the percentage of match placements with 91%, compared to the national match placement average of 82%.

Bold Pursuits in Health and Well-Being

Body and Soul: Bold pursuits in health and the arts. Includes an image of a large copper shell sculpture.
March 20, 2023
College of Pharmacy Dean Sam Poloyac participated in a panel discussion from the 2023 Texas Leadership Society Luncheon on The University of Texas at Austin's bold pursuits in health and well-being. The discussion was moderated by UT President Jay Hartzell.

Pharmacists: The Most Accessible Healthcare Provider, Unless You Have a Substance Use Disorder

White pill bottle with white pills on a black background.
August 23, 2022
P4 students, Megan Yeung, Kami Johnston and Morgan Murchison co-author a peer-reviewed blog in Pulses encouraging educators to adapt to reflect the specific needs of people who use drugs and patients with substance use disorders. This blog also highlights UT Pharmacy as a U.S. leader in substance use disorder and harm reduction education for Pharm.D. students.

Celebrating the Latest Awards, Appointments and Achievements from the UT Pharmacy Community

Pharmacy building on UT campus
July 5, 2022
From student scholarships to national recognition awards to prestigious appointments, the UT Pharmacy community has a lot to celebrate and be proud of right now.

Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse

A pharmacist holding a box of medication.
June 13, 2022
Tara Law from Time writes about how few pharmacies carry buprenorphine, a life-saving drug to help treat opioid use disorder (OUD). Lucas Hill, Pharm.D., BCACP, director of the college's Pharmacy Addictions Research & Medicine (PhARM) program, offers his insight on the issue, and how the DEA's crackdown of the drug puts OUD patients at risk.

Ginsburg appointed to Provost’s Distinguished Service Academy

Headshot of Dr. Diane Ginsburg.
May 5, 2022
Dr. Diane Ginsburg has been appointed to the Provost’s Distinguished Service Academy for her excellence in mentorship and demonstrated mastery across scholarship, teaching, leadership and service.

UT Pharmacy Earns Highest Residency Match Rate in Texas

#1 Residency Match Placement in Texas
April 19, 2022
Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.

Opioid Use Disorder Paper Earns ACCP Award

A box of naloxone vials.
October 8, 2021
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.